Basilea Pharmaceutica

About:

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.

Website: http://basilea.com

Top Investors: Biomedical Advanced Research and Development Authority (BARDA), Athyrium Capital Management LP, CARB-X, U.S. Department of Health & Human Services

Description:

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and nonresponse to current treatment options.